Keck School Faculty

Julie Culver

Julie Culver

Instructor of Clinical Medicine
Medicine
USC Norris Comprehensive Cancer Center Health Sciences Campus Los Angeles

Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum Hum Mutat. 2022 May 05. . View in PubMed

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients Cancer. 2021 04 15; 127(8):1275-1285. . View in PubMed

Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells Gynecol Oncol. 2020 12; 159(3):869-876. . View in PubMed

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D J Natl Cancer Inst. 2020 12 14; 112(12):1242-1250. . View in PubMed

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families J Clin Oncol. 2020 03 01; 38(7):674-685. . View in PubMed

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk JCO Precis Oncol. 2019 Mar; 3. . View in PubMed

Patient communication of cancer genetic test results in a diverse population Transl Behav Med. 2018 01 29; 8(1):85-94. . View in PubMed

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices NPJ Genom Med. 2018; 3:7. . View in PubMed

Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges JCO Precis Oncol. 2017 Nov; 1:1-12. . View in PubMed

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort Cancer Genet. 2016 Apr; 209(4):130-7. . View in PubMed

A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer Cancer Genet. 2016 Mar; 209(3):75-81. . View in PubMed

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress Clin Genet. 2013 Nov; 84(5):464-72. . View in PubMed

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions Mol Diagn Ther. 2013 Feb; 17(1):31-47. . View in PubMed

Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs J Cancer Educ. 2012 Jun; 27(3):467-77. . View in PubMed

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors J Genet Couns. 2012 Apr; 21(2):151-61. . View in PubMed

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine CA Cancer J Clin. 2011 Sep-Oct; 61(5):327-59. . View in PubMed

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce Genet Med. 2011 Sep; 13(9):832-40. . View in PubMed

Development and evaluation of a decision aid for BRCA carriers with breast cancer J Genet Couns. 2011 Jun; 20(3):294-307. . View in PubMed

Recurrence and variability of germline EPCAM deletions in Lynch syndrome Hum Mutat. 2011 Apr; 32(4):407-14. . View in PubMed

Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates Patient Educ Couns. 2011 Apr; 83(1):92-8. . View in PubMed

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study Lancet Oncol. 2011 Jan; 12(1):49-55. . View in PubMed

Limited family structure and BRCA gene mutation status in single cases of breast cancer JAMA. 2007 Jun 20; 297(23):2587-95. . View in PubMed

Results of a randomized study of telephone versus in-person breast cancer risk counseling Patient Educ Couns. 2006 Dec; 64(1-3):96-103. . View in PubMed

Assessing breast cancer risk and BRCA1/2 carrier probability Breast Dis. 2006-2007; 27:5-20. . View in PubMed

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors J Genet Couns. 2004 Apr; 13(2):83-114. . View in PubMed

Genetic counseling for women with an intermediate family history of breast cancer Am J Med Genet. 2000 Feb 28; 90(5):361-8. . View in PubMed

Julie Culver, MS, LCGC, CCRP is the Director of Genetic Counseling at the USC Norris Cancer Hospital and is a Clinical Instructor of Medicine in the USC Keck School of Medicine. She provides cancer genetic counseling for individuals and family at risk of having inherited cancer syndromes.
Her research pertains to genetic testing for hereditary cancer, medical decision-making following genetic testing, implementation of genetic testing, and participant engagement in genomics research. She has taught breast cancer risk assessment to health professionals and students since 2004.
sc ctsi logoPowered by SC CTSI